Which breathing aid works best for Guillain-Barré? new trial aims to find out
NCT ID NCT06996509
First seen Jun 25, 2026 · Last updated Jun 25, 2026
Summary
This study tests two breathing support devices—high-velocity nasal cannula (HVNI) and non-invasive ventilation (NIV)—in 80 adults with Guillain-Barré syndrome who have serious breathing trouble. The goal is to see which device helps more patients avoid needing a breathing tube within 30 days. Researchers will also measure comfort, ICU and hospital stays, and survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GUILLAIN-BARRE SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Assuit Univeristy
RECRUITINGAsyut, Assuit, 71515, Egypt
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
-
Faculty of Medicine - Assiut University Hospitals - Assiut University - Egypt
RECRUITINGAsyut, 71515, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
High-Velocity Nasal Insufflation (HVNI) device and Non-Invasive Ventilation (NIV) device
What this could lead to
If one device works better, it could help more Guillain-Barré patients breathe without needing a breathing tube, reducing complications and hospital stays.
What could go wrong
This is a small, early-stage trial (80 patients) at one hospital, so results may not apply to everyone. Both devices are already used, so no major new risks, but individual responses vary.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.